GlassScriptPhysician profile
Jerry A Rubin
NPI 1134136997
$644.15
in general payments reported to CMS, 2019-2025
12 companies · $38.52 in 2025
The $38.52 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $49.08 · 2021: $103 · 2023: $40.91 · 2025: $38.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Access Systems, INC. | $134.61 | 2019 | |
| Acell, INC. | $124.99 | 2019 | |
| Medtronic USA, INC. | $123.04 | 2019 | |
| Dynasplint Systems INC. | $118.24 | 2019-2021 | |
| Endo USA, INC. | $22.03 | 2025 | Xiaflex |
| Zimvie INC. | $20.95 | 2023 | |
| Orthofix Medical, INC. | $19.96 | 2023 | Physio-Stim |
| Sonex Health, INC. | $18.35 | 2020 | |
| Bioventus LLC | $17.10 | 2020 | |
| Depuy Synthes Sales INC. | $16.49 | 2025 | Dynatape |
| Endo Pharmaceuticals INC. | $14.76 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.